Tai San Noah Lim
Direttore/Membro del Consiglio presso Mirxes Holding Co., Ltd.
Posizioni attive di Tai San Noah Lim
Società | Posizione | Inizio | Fine |
---|---|---|---|
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Direttore/Membro del Consiglio | 01/01/2021 | - |
Independent Dir/Board Member | 01/01/2021 | - |
Storia della carriera di Tai San Noah Lim
Formazione di Tai San Noah Lim
National University of Singapore | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Statistiche
Distribuzione geografica
Singapore | 3 |
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Undergraduate Degree | 1 |
Settori
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | Finance |
- Borsa valori
- Insiders
- Tai San Noah Lim
- Esperienza